Tesaro names chief commercial officer
This article was originally published in Scrip
Waltham, Massachusetts-based Tesaro, an oncology-focused biopharmaceutical company, has appointed Grant C Bogle to the newly created position of senior vice-president and chief commercial officer. In this role, Mr Bogle will report to Lonnie Moulder, CEO of Tesaro, and will lead the company's marketing, sales, and market access teams. Most recently he was senior vice-president, pharmaceutical and biotech solutions at McKesson Specialty Health, where he led the informatics, health economics and outcomes research, reimbursement access and safety services, and US Oncology Clinical Research business units.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.